Pathstone Family Office, LLC Neogenomics Inc Transaction History

Pathstone Family Office, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Oct 23, 2023	BUY	$6.45 - $12.07 $183,263 - $342,944	28,413 New	28,413 $262,000
Q4 2022 Feb 13, 2023	BUY	$6.45 - $12.07 $107,953 - $202,015	16,737 Added 143.35%	28,413 $262,000
Q3 2022 Nov 14, 2022	BUY	$7.86 - $12.91 $91,773 - $150,737	11,676 New	11,676 $100,000
Q1 2021 May 14, 2021	SELL	$41.56 - $59.88 $540 - $778	-13 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$33.26 - $40.48 $432 - $526	-13 Reduced 50.0%	13 $0
Q2 2020 Aug 14, 2020	SELL	$24.21 - $31.02 $1,791 - $2,295	-74 Reduced 74.0%	26 $0
Q1 2020 Jun 11, 2020	BUY	$20.5 - $34.53 $2,050 - $3,453	100 New	100 $3,000

291

124M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.76B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

Stay updated on Pathstone Family Office, LLC with notifications on news.